Abstract
Exogenous nucleotide supplementation during times of rapid growth and stress is preferred because de novo synthesis is insufficient and energetically a costly process. To overcome inefficient utilization of dietary nucleotides due to intestinal cell repulsion and dependency on pH, an efficient controlled delivery system based on chitosan nanoparticles (NPs) was developed. The effects of these (0.2% and 0.4%) RNA-loaded chitosan NPs (Chitosan: RNA ratio 2:1), 0.4% bare RNA, and 0.8% chitosan NPs on productive efficiency (growth rate, feed conversion and protein efficiency ratio), body composition, organo-somatic indices, haemato-biochemical and immune responses (WBC count, phagocytic activity, serum lysozyme, serum total protein and albumin : globulin ratio) and survival of Labeo rohita fish fingerlings, following challenge with pathogenic bacteria were evaluated. Dietary chitosan NPs were found not to affect productive efficiency, but improved (P < 0.01) immunity by increasing WBC and phagocytic activity. Dietary RNA significantly improved (P < 0.01) productive efficiency, immunity and survival, which was further potentiated (P < 0.01) by its nanosized delivery by loading onto chitosan NPs. Blood glucose, haemoglobin, RBC count, serum uric acid and whole body composition were unaffected (P > 0.05) by dietary treatments. RNA-loaded chitosan NPs increased hepato- and viscerosomatic indices. The activity of metabolic enzymes (intestinal and liver alkaline phosphatase, alanine- and aspartateamino transferases, lactate- and malate-dehydrogeneases) corresponded with the performance of the respective diets. As growth, immunity and disease resistance in fish given dietary nano-sized RNA were significantly higher than in those given bare RNA or chitosan alone, and as nanoformulation reduced the usage of individual components by half, the use of RNA-loaded chitosan NPs can be favoured in the feed/food industry over chitosan and RNA alone.
Keywords: Body composition, chitosan nanoparticles, disease resistance, fish, immunity, performance, RNA.
Graphical Abstract
Current Nanoscience
Title:RNA-Loaded Chitosan Nanoparticles for Enhanced Growth, Immunostimulation and Disease Resistance in Fish
Volume: 10 Issue: 3
Author(s): S. Ferosekhan, Subodh Gupta, Arvind R. Singh, Mohd. Ashraf Rather, Rakhi Kumari, Dushyant C. Kothari, Asim Kumar Pal and Sanjay Balkrishna Jadhao
Affiliation:
Keywords: Body composition, chitosan nanoparticles, disease resistance, fish, immunity, performance, RNA.
Abstract: Exogenous nucleotide supplementation during times of rapid growth and stress is preferred because de novo synthesis is insufficient and energetically a costly process. To overcome inefficient utilization of dietary nucleotides due to intestinal cell repulsion and dependency on pH, an efficient controlled delivery system based on chitosan nanoparticles (NPs) was developed. The effects of these (0.2% and 0.4%) RNA-loaded chitosan NPs (Chitosan: RNA ratio 2:1), 0.4% bare RNA, and 0.8% chitosan NPs on productive efficiency (growth rate, feed conversion and protein efficiency ratio), body composition, organo-somatic indices, haemato-biochemical and immune responses (WBC count, phagocytic activity, serum lysozyme, serum total protein and albumin : globulin ratio) and survival of Labeo rohita fish fingerlings, following challenge with pathogenic bacteria were evaluated. Dietary chitosan NPs were found not to affect productive efficiency, but improved (P < 0.01) immunity by increasing WBC and phagocytic activity. Dietary RNA significantly improved (P < 0.01) productive efficiency, immunity and survival, which was further potentiated (P < 0.01) by its nanosized delivery by loading onto chitosan NPs. Blood glucose, haemoglobin, RBC count, serum uric acid and whole body composition were unaffected (P > 0.05) by dietary treatments. RNA-loaded chitosan NPs increased hepato- and viscerosomatic indices. The activity of metabolic enzymes (intestinal and liver alkaline phosphatase, alanine- and aspartateamino transferases, lactate- and malate-dehydrogeneases) corresponded with the performance of the respective diets. As growth, immunity and disease resistance in fish given dietary nano-sized RNA were significantly higher than in those given bare RNA or chitosan alone, and as nanoformulation reduced the usage of individual components by half, the use of RNA-loaded chitosan NPs can be favoured in the feed/food industry over chitosan and RNA alone.
Export Options
About this article
Cite this article as:
Ferosekhan S., Gupta Subodh, Singh R. Arvind, Rather Ashraf Mohd., Kumari Rakhi, Kothari C. Dushyant, Pal Kumar Asim and Jadhao Balkrishna Sanjay, RNA-Loaded Chitosan Nanoparticles for Enhanced Growth, Immunostimulation and Disease Resistance in Fish, Current Nanoscience 2014; 10 (3) . https://dx.doi.org/10.2174/1573413710666140115220300
DOI https://dx.doi.org/10.2174/1573413710666140115220300 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Screening of Early and Late Onset Alzheimer’s Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy
Current Alzheimer Research Mechanical Ventilation of the Neonate: Principles and Strategies
Current Respiratory Medicine Reviews γ-Secretase: Structure, Function, and Modulation for Alzheimers Disease
Current Topics in Medicinal Chemistry Synthetic LXR Agonist Suppresses Endogenous Cholesterol Biosynthesis and Efficiently Lowers Plasma Cholesterol
Current Pharmaceutical Biotechnology Nicotinic Receptors in Neurodegeneration
Current Neuropharmacology Prognosis and Treatment of Ventricular Arrhythmias Following Myocardial Infarction
Current Cardiology Reviews Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
Anti-Cancer Agents in Medicinal Chemistry G Protein-Activated Inwardly Rectifying Potassium Channels as Potential Therapeutic Targets
Current Pharmaceutical Design The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age
Current Neuropharmacology Enhancing cAMP Levels as Strategy for the Treatment of Neuropsychiatric Disorders
Current Topics in Medicinal Chemistry Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review
Current Neuropharmacology Astaxanthin, the Natural Antioxidant, Reduces Reserpine Induced Depression in Mice
Current Bioactive Compounds Survivin Modulators: An Updated Patent Review (2011 - 2015)
Recent Patents on Anti-Cancer Drug Discovery Clinical Pharmacotherapy for Obesity: Current Drugs and Those in Advanced Development
Current Drug Targets Chemical Biology of mGlu4 Receptor Activation: Dogmas, Challenges, Strategies and Opportunities
Current Topics in Medicinal Chemistry Impaired DNA Damage Repair as a Common Feature of Neurodegenerative Diseases and Psychiatric Disorders
Current Molecular Medicine Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review of Recent Data
Current Psychopharmacology Pharmaceutical Nanotechnology United States Patent Watch (October – December 2014)
Pharmaceutical Nanotechnology Development and Characterization of Metformin Loaded Pectin Nanoparticles for T2 Diabetes Mellitus
Pharmaceutical Nanotechnology Respiration and Energy Homeostasis
Current Respiratory Medicine Reviews